Liquid Biopsy Market Liquid Biopsy Technology Sales Report 2020

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

Report Table of Contents

1. Introduction to Liquid Biopsy: A Non-Invasive, Game-Changer Diagnostic Tool

2. Mechanism of Action: Major Components of Liquid Biopsy
2.1 Circulating Tumor Cells
2.1.1 Parameters Guiding Circulating Cell Tumors
2.2 Circulating Tumor Nucleic Acids (ctNA)
2.2.1 Cell-Free Tumor DNA
2.2.2 Other Circulatory Tumor Nucleic Acid: microRNA, mRNA & Long Non-Coding RNAs
2.3 Exosomes

3. Circulatory Tumor Cells: A Snapshot; Its History, Biologics, Selection Method, Detection Procedures, Enrichment Procedures, Analysis & Disease Monitoring
3.1 The History & Introduction
3.2 The Selection Methods
3.3 The Analysis Methodologies
3.4 The Scope of Disease Monitoring
3.5 The Biologics of Circulatory Tumor Cells

4. Diagnostic Technological Advancement Supplementing Liquid Biopsy Market
4.1 Glimpses to the Next Generation Sequencing Techniques
4.2 Methodologies Involved in the Next Generation Sequencing
4.2.1 Genomics
4.2.2 Transcriptomics
4.2.3 Epigenomics
4.3 Flowchart Depicting Genomic Analysis Using Next Generation Sequencing
4.3.1 A Basic Workflow of Next Generation Sequencers
4.3.2 Integrated Data Analysis
4.4 Pricing Implications of Next Generation Sequencing On the Liquid Biopsy Market

5. Clinical Investigation Using Cell-Free Circulating Tumor DNA for Different Indications
5.1 Lung Cancer
5.2 Breast Cancer
5.3 Colorectal Cancer
5.4 Melanoma
5.5 Gastric Cancer
5.6 Prostate Cancer
5.7 Brain Cancer
5.8 Detection & Monitoring of Type 1 Diabetes
5.9 Pancreatic Cancer
5.10 Renal Cancer
5.11 Retinoblastoma

6. Combinational Analysis on the Working of Circulating Tumor Cells & Cell-Free Tumor DNA

7. Business Model of Liquid Biopsy Market: A Hotbed for Start-Ups and Venture Capital Funding

8. Other Market Modalities Associated With Liquid Biopsy
8.1 Accreditation through Clinical Laboratory Improvement Amendments (CLIA) Testing: Green Signal for Liquid Biopsy
8.2 The Impact of Service Providers in Liquid Biopsy Market
8.3 The Role of Liquid Biopsy In The Light Of Insurance Associated Issues

9. Liquid Biopsy Market Share in North America, Europe, Asia- Pacific & Rest of the World
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of the World
9.4.1 Africa
9.4.2 South America
9.4.3 Middle East

10. Market Drivers: Clinical Utilities of Liquid Biopsy. Why Do We Need Them?
10.1 Help Monitor Minimal Residue Disease
10.2 Help Track Emergence of Drug Resistance
10.3 Liquid Biopsy Used As a Predictive & Pharmacodynamic Biomarker
10.3.1 Cell-Free Tumor DNA as Predictive Biomarker
10.3.2 Cell-Free Tumor DNA as Pharmacodynamic Biomarker

11. Market Trends in Liquid Biopsy. Is The Era Of Tissue Biopsy Coming To An End?

12. Market Share of Different Liquid Biopsy Techniques

13. Market Challenges: Liquid biopsy, A Revolution in Cancer Diagnosis; a Myth or a Reality?
13.1 Complex Immuno-Biochemical Mechanism of Cancer Cells
13.2 The Risk of False Positive Liquid Biopsy Test
13.3 The Risk of False Negative Liquid Biopsy Test
13.4 Inconclusive Nature of Cancer Biomarkers
13.5 Lack of Standardized Protocols
13.6 Business Model Based Challenges
13.7 Issues Related To Regulatory Framework

14. Conclusion: Liquid Biopsy; Real-Time & Revolutionary Novel Diagnostic Tool

15. Competitive Landscape
15.1 AdnaGen (QIAGEN)
15.2 Agena Bioscience
15.3 Angle
15.4 ApoCell
15.5 Biocept
15.6 BioFluidica
15.7 Bio-Rad Laboratories
15.8 Boreal Genomics
15.9 Chronix Biomedical
15.10 Clearbridge BioMedics
15.11 Cynvenio
15.12 Cytotrack
15.13 Epic Sciences
15.14 Exosome Diagnostics
15.15 Fluidigm
15.16 Fluxion Biosciences
15.17 Genomic Health
15.18 Guardant Health
15.19 HansaBiomed
15.20 Horizon Discovery
15.21 iCellate
15.22 Illumina
15.23 Inivata
15.24 Janssen Diagnostics
15.25 Molecular MD
15.26 Myriad Genetics
15.27 Natera

Download Report: https://www.kuickresearch.com/report-Global-Liquid-Biopsy-Market-Opportunity-&-Technology-Outlook-2020.php

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.